Cargando…

SAT-305 Hyperactive Behavioral Change during Combination Treatment of Aromatase Inhibitor and Recombinant Human Growth Hormone in Early Puberty Patient: A Case Report

Aromatase inhibitor (AI) is a drug that blocks the converstion of androgens to estrogens, originally approved by FDA as a treatment of breast cancer in postmenopausal women. In several studies, it has been proposed that AI can be used as a off-label treatment to improve the final adult height in sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Ju-hee, Kim, Dae Hyun, Suh, Chae-ri, Kim, So Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551995/ http://dx.doi.org/10.1210/js.2019-SAT-305

Ejemplares similares

SAT-308 Obsessive and Compulsive Behavioral Change during Combination Treatment of Aromatase Inhibitor and Recombinant Human Growth Hormone in Early Puberty Patient: A Case Report
por: Choi, Ju-hee, et al.
Publicado: (2019)

SAT-303 Combined Treatment of Gonadotropin Releasing Hormone Agonist and Recombinant Human Growth Hormone in Cental Precocious Puberty Patient with Underlying Leri Weill Dyschondrosteosis
por: Choi, Ju-hee, et al.
Publicado: (2019)

SAT-304 Unexplained Asymptomatic Hyperestrogenism in Central Precocious Puberty Patient Treated with Gonadotropin Releasing Hormone Agonist
por: Kim, Dae Hyun, et al.
Publicado: (2019)

SAT-307 Sudden Unexpected Vaginal Bleeding Caused by Temporal Reactivation of Hypothalamic-Hypophyseal-Gonadal Axis during Gonadotropin Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Kim, Dae Hyun, et al.
Publicado: (2019)

SAT-292 Superimposed Peripheral Precocious Puberty Caused by Autonomous Ovarian Follicular Cyst in Being Treated Central Precocious Puberty Patient: Underlying Condition of Herlyn-Werner-Wunderlich Syndrome
por: Kim, Dae Hyun, et al.
Publicado: (2019)

SAT-101 The Booster Effect of Aromatase Inhibitor to Overcome Waning Effect of Recombinant Human Growth Hormone
por: Kim, Dae Hyun, et al.
Publicado: (2020)

SAT-102 Height Improvement with Recombinant Human Growth Hormone Therapy at Terminal Stage of Growth
por: Kim, Dae Hyun, et al.
Publicado: (2020)

SAT-296 Congenital Adrenal Hyperplasia Presenting as Central Precocious Puberty
por: Malineni, Vikas, et al.
Publicado: (2019)

MON-061 A Case of Central Precocious Puberty Patient with Arnold Chiari Malformation, Type I
por: Kim, Dae Hyun, et al.
Publicado: (2020)

SAT-073 Testicular Abnormalities in the Absence of Precocious Puberty in Mccune-Albright Syndrome
por: Verma, Arushi, et al.
Publicado: (2020)

SUN-086 Pilot Study Using Aromatase Inhibitor in Puberty of Boys With Partial Androgen Insensitivity: Report of Three Cases
por: Maciel-Guerra, Andrea Trevas, et al.
Publicado: (2020)

MON-063 Rare Cases of Local and Systemic Allergic Reactions Associated with Recombinant Human Growth Hormone Treatment Including Fixed Drug Eruption and Anaphylaxis
por: Kim, Dae Hyun, et al.
Publicado: (2020)

MON-243 The Difference of Body Mass Index Score before and after Gonadotropin-Releasing Hormone Agonist Treatment in Cerntral Precocious Puberty Girls
por: Choi, Yujung, et al.
Publicado: (2019)

SAT-LB047 Circulating IGF-1, MKRN3, and Kisspeptin in Girls during the Onset of Puberty
por: Yang, Fan
Publicado: (2019)

SAT-278 Changes in Biochemical and Electrocardiographic Findings During Insulin Tolerance Test
por: Choi, Han Saem, et al.
Publicado: (2019)

MON-069 Uncontrolled Central Precocious Puberty Patient Against GnRH Agonist, After Showing Granuloma Formation and Sterile Abscess to Both Leuprorelin Acetate and Triptorelin Actate
por: Kim, Dae Hyun, et al.
Publicado: (2020)

SAT-286 A Previously Undescribed Combination of Aromatase Deficiency and Non-Classical Congenital Adrenal Hyperplasia in an Hispanic Teenage Male
por: Gottesman, Bethany, et al.
Publicado: (2019)

SAT-290 Expanded Phenotype Associated with RNF135 Intragenic Deletion in a Girl with Peripheral Precocious Puberty
por: Danowitz, Melinda, et al.
Publicado: (2019)

Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome
por: Binder, Gerhard, et al.
Publicado: (2021)

MON-241 Relationship between Final Height and Birth Weight after Gonadotropin-Releasing Hormone Agonist Treatment in Girls with Central Precocious Puberty
por: Kim, Eun Young, et al.
Publicado: (2019)

LBODP081 The Relationship Between Body Mass Index Changes And Bone Age Progression During Gonadotropin-releasing Hormone Agonist Treatment In Girls With Idiopathic Central Precocious Puberty
por: Kim, Seulki, et al.
Publicado: (2022)

ODP386 Growth Velocity and Growth Hormone Deficiency During Puberty
por: Currais, Carolina, et al.
Publicado: (2022)

SAT-106 Growth Hormone Treatment Response in Children
por: Rath, Mitchell, et al.
Publicado: (2020)

OR18-2 Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
por: Argente, Jesús, et al.
Publicado: (2022)

SAT-108 Growth Hormone Deficiency in a Patient with Ectodermal Dysplasia
por: Alkhaled, Lina, et al.
Publicado: (2020)

SAT-288 Successful Virilization of a PAIS Patient with a Missense Mutation In The Ligand-binding Domain Of The Androgen Receptor with Combined High-dose Testosterone and Aromatase Inhibitor
por: MORAES, DANIELA, et al.
Publicado: (2019)

SAT-247 Two-Year Treatment with Metformin during Puberty Is Associated with Improvements in Body Composition, but Not in Insulin Sensitivity or β-Cell Function in Obese Youth
por: Kelsey, Megan, et al.
Publicado: (2019)

SAT348 Changes In BMI Z-score After Presentation For Early Breast Budding Is Associated With Rapidly Progressive Puberty And Treatment With GnRH Analogues
por: Jung, Hae Woon, et al.
Publicado: (2023)

SAT-070 Nutritional Deficiency of Calcium Mimicking P Seudohypoparathyroidism
por: Lee, Yoonji, et al.
Publicado: (2020)

SAT-090 Factors Affecting IGF-1 Level and Correlation with Growth Response During Growth Hormone Treatment in LGS Patients
por: Kim, Jihyun, et al.
Publicado: (2020)

SAT-284 Sex Hormone Replacement Therapy in Turner Syndrome and the Impact on Morbidity and Mortality
por: Viuff, Mette, et al.
Publicado: (2019)

SAT-249 Comparison of Different Criteria for the Definition of Insulin Resistance and Its Relation with Metabolic Risk in Overweight and Obese Adolescents
por: Lee, Seonhwa, et al.
Publicado: (2019)

SAT-246 Insulin-Like Growth Factor-1 and Binding Protein-3 in Children with Metabolic Syndrome
por: Ahn, Moon-Bae, et al.
Publicado: (2019)

THU194 Growth Pattern And Related Predictors Of Gonadotropin-releasing Hormone Analog Treatment In Girls With Precocious Puberty
por: Ouyang, Lixue, et al.
Publicado: (2023)

SAT-088 The Incidence of Neurological Symptoms During Growth Hormone Therapy in Patients with Chiari Malformation
por: Alexandrov, Alice, et al.
Publicado: (2020)

SAT-107 Improved Adult Height in Brazilian Turner Syndrome Patients Treated with Growth Hormone
por: Scalco, Renata Da Cunha, et al.
Publicado: (2020)

SUN-259 Recombinant Growth Hormone Therapy for Children with Turner Syndrome in Korea: A Phase III Randomized Trial
por: Kim, Jinsup, et al.
Publicado: (2019)

Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
por: Shi, Yuzhen, et al.
Publicado: (2022)

SAT-105 The Natural History of Pituitary Cysts in Patients with Growth Hormone Deficiency and Idiopathic Short Stature
por: El-Naghy, Zeyad, et al.
Publicado: (2020)

THU167 Trends Of Recombinant Human Growth Hormone Treatment In Korea: Data From The Health Insurance Review And Assessment Service 2015-2020
por: Kim, Jaehyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e2cs1n01mpnlceu8dv0l5u4936